Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Myrtleciclib

Next Previous
X
Search
Drug Profile

Myrtleciclib

Alternative Names: Myrtleciclib - ViroStatics; VS 2370; VS2-370 - Virostatics/Vichem Chemie

Latest Information Update: 17 Jun 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Vichem Chemie
  • Developer Virostatics
  • Class Antineoplastics; Antivirals; Small molecules
  • Mechanism of Action Cyclin-dependent kinase 4 inhibitors; Cyclin-dependent kinase 6 inhibitors; Cyclin-dependent kinase 9 inhibitors; Proto-oncogene protein c-myc inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Cancer

Highest Development Phases

  • Preclinical Cancer; HIV infections

Most Recent Events

  • 17 Jun 2024 Virostatics has patent protection for Myrtleciclib worldwide, prior to June 2024 (Virostatics pipeline, June 2024)
  • 10 Feb 2023 Virostatics licensed VS2 370 from Vichem (http://www.virostatics.com/research-and-development/)
  • 09 Dec 2022 VS2 370 - Virostatics is available for licensing as of 09 Dec 2022. http://www.virostatics.com/research-and-development/

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top